Summary:
- This article discusses the results of a clinical study on a new medication-driven weight loss treatment developed by Galderma, a leading dermatology company.
- The study found that participants who took the medication for 9 months experienced significant weight loss, with an average reduction of 15% of their body weight.
- The medication works by targeting specific receptors in the body to reduce appetite and increase metabolism, providing a new option for individuals struggling with obesity and related health issues.